Pfizer has asked Japan’s health ministry for approval to use its vaccine on children aged 5 to 11, the company said in a statement, Report informs referring to Nikkei Asia.
Pfizer’s vaccine - developed with BioNTech - was the first jab approved for the general public in February.
The vaccine is currently for persons aged 12 and above. If approved, Pfizer’s jab will be the first one in Japan available for children under 11.
To date, 77.8% of the population has received at least one dose in Japan, where Pfizer/BioNTech, Moderna or AstraZeneca coronavirus vaccines are allowed. 73.1% of the Japanese population are fully vaccinated.